Home » Stocks » BIOL


Stock Price: $0.260 USD -0.013 (-4.87%)
Updated Oct 30, 2020 4:00 PM EDT - Market closed
After-hours: $0.273 +0.013 (5.00%) Oct 30, 6:52 PM

Stock Price Chart

Key Info

Market Cap 23.97M
Revenue (ttm) 26.55M
Net Income (ttm) -19.77M
Shares Out 92.19M
EPS (ttm) -0.67
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 30, 2020
Last Price $0.260
Previous Close $0.273
Change ($) -0.013
Change (%) -4.87%
Day's Open 0.268
Day's Range 0.260 - 0.273
Day's Volume 1,238,148
52-Week Range 0.211 - 0.960

More Stats

Market Cap 23.97M
Enterprise Value 34.90M
Earnings Date (est) Nov 4, 2020
Ex-Dividend Date n/a
Shares Outstanding 92.19M
Float 84.80M
EPS (basic) -0.67
EPS (diluted) -0.67
FCF / Share -0.41
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 327,327
Short Ratio 0.14
Short % of Float 0.39%
Beta 1.84
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 0.90
PB Ratio 21.97
Revenue 26.55M
Operating Income -17.26M
Net Income -19.77M
Free Cash Flow -15.62M
Net Cash -10.94M
Net Cash / Share -0.12
Gross Margin 53.82%
Operating Margin -65.02%
Profit Margin -74.50%
FCF Margin -58.84%
ROA -35.87%
ROE -774.75%
ROIC -122.30%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (4)

Buy 4
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(469.23% upside)
Current: $0.260
Target: 1.48
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth-18.1%-1.64%-9.43%6.88%1.72%-15.55%-1.61%17.39%86.3%-
Gross Profit14.2916.9015.1320.3115.9518.1721.5326.4821.328.83
Operating Income-15.62-20.89-18.04-14.96-19.92-17.94-11.00-2.53-4.00-11.50
Net Income-17.86-21.52-16.85-15.37-20.28-18.93-11.48-3.06-4.49-12.02
Shares Outstanding23.2020.5914.7512.1311.648.456.556.436.125.36
Earnings Per Share-0.77-1.05-1.41-1.45-1.75-2.25-1.75-0.50-0.75-2.26
Operating Cash Flow-12.75-14.15-18.41-10.60-17.77-16.20-9.30-1.66-13.32-3.81
Capital Expenditures-0.21-0.52-0.75-1.41-1.78-0.20-0.68-0.68-0.43-0.24
Free Cash Flow-12.95-14.67-19.16-12.01-19.55-16.40-9.97-2.35-13.75-4.05
Cash & Equivalents6.108.3611.909.1811.9031.561.442.543.311.69
Total Debt13.4710.84--0.16-4.631.64-2.62
Net Cash / Debt-7.37-2.4811.909.1811.7431.56-3.190.913.31-0.93
Book Value0.3811.0929.2622.0724.9342.068.4811.7912.57-3.05
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name BIOLASE, Inc.
Country United States
Employees 157
CEO Todd A. Norbe

Stock Information

Ticker Symbol BIOL
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: BIOL
IPO Date November 13, 1992


BIOLASE, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode laser systems to perform soft tissue, hygiene, cosmetic procedures, and teeth whitening, as well as to provide temporary pain relief; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces, and teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Irvine, California.